Giardia lamblia is a common intestinal-dwelling protozoan and causes diarrhoea in humans and animals worldwide. For several years, a small number of drugs such as the 5-nitroimidazole metronidazole (MET) or the thiazolide nitazoxanide (NTZ) have been used for chemotherapy against giardiasis. However, various pre-clinical and clinical investigations revealed that antigiardial chemotherapy may be complicated by emergence of giardial resistance to these drugs. The present study addressed the question if isoflavones with antigiardial activity, such as daidzein (DAI) or formononetin (FOR), may serve as alternative compounds for treatment of giardiasis. For this purpose, the potential of G. lamblia clone WB C6 to form resistance to FOR and related isoflavones was tested in vitro. In the line of these experiments, a clone (C3) resistant to isoflavones, but sensitive to MET and NTZ, was generated. Affinity chromatography on DAI-agarose using cell-free extracts of G. lamblia trophozoites resulted in the isolation of a polypeptide of approximately 40 kDa, which was identified by mass spectrometry as a nucleoside hydrolase (NH) homologue (EAA37551.1). In a nucleoside hydrolase assay, recombinant NH hydrolysed all nucleosides with a preference for purine nucleosides and was inhibited by isoflavones. Using quantitative RT-PCR, the expression of genes that are potentially involved in resistance formation was analysed, namely NH and genes encoding variant surface proteins (VSPs, TSA417). The transcript level of the potential target NH was found to be significantly reduced in C3. Moreover, drastic changes were observed in VSP gene expression. This may indicate that resistance formation in Giardia against isoflavones is linked to, and possibly mediated by, altered gene expression. Taken together, our results suggest FOR or related isoflavones as an alternative antigiardial agent to overcome potential problems of resistance to drugs like MET or NTZ. However, the capacity of Giardia to develop resistance to isoflavones can potentially interfere with this alternative treatment of the disease.
AltschulS. F.,
MaddenT. L.,
SchäfferA. A.,
ZhangJ.,
ZhangZ.,
MillerW.,
LipmanD. L.1997; Gapped blast and psi-blast: a new generation of protein database search programs. Nucleic Acids Res 25:3389–3402
DakoraF. D.,
PhillipsD. A.1996; Diverse functions of isoflavonoids in legumes transcend anti-microbial definitions of phytoalexins. Physiol Mol Plant Pathol 49:1–20
EyP. L.,
DaveyR. A.,
DuffieldG. A.1992; A low-affinity nucleobase transporter in the protozoan parasite Giardia intestinalis . Biochim Biophys Acta1109179–186
GeroA. M.,
KangE. W.,
HarveyJ. E.,
SchofieldP. J.,
ClinchK.,
FurneauxR. H.2000; Trichomonas vaginalis : detection of nucleoside hydrolase activity as a potential screening procedure. Exp Parasitol 94:125–128
KhanI. A.,
AveryM. A.,
BurandtC. L.,
GoinsD. K.,
MikellJ. R.,
NashT. E.,
AzadeganA.,
WalkerL. A.2000; Antigiardial activity of isoflavones from Dalbergia frutescens bark. J Nat Prod 63:1414–1416
KulakovaL.,
SingerS. M.,
ConradJ.,
NashT. E.2006; Epigenetic mechanisms are involved in the control of Giardia lamblia antigenic variation. Mol Microbiol 61:1533–1542
MegraudF.,
OcchialiniA.,
RossignolJ.-F.1998; Nitazoxanide: a potential drug for eradication of Helicobacter pylori with no cross-resistance to metronidazole. Antimicrob Agents Chemother 42:2836–2840
MüllerJ.,
RühleG.,
MüllerN.,
RossignolJ. F.,
HemphillA.2006; In vitro effects of thiazolides on Giardia lamblia WB clone C6 cultured axenically and in coculture with CaCo2 cells. Antimicrob Agents Chemother 50:162–170
NashT. E.,
MerrittJ. W.Jr,
ConradJ. T.1991; Isolate and epitope variability in susceptibility of Giardia lamblia to intestinal proteases. Infect Immun 59:1334–1340
UpcroftJ. A.,
CampbellR. W.,
BenakliK.,
UpcroftP.,
VanelleP.1999; Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas , and Entamoeba spp. Antimicrob Agents Chemother 43:73–76
UpcroftJ. A.,
DunnL. A.,
WrightJ. M.,
BenakliK.,
UpcroftP.,
VanelleP.2006; 5-nitroimidazole drugs effective against metronidazole-resistant Trichomonas vaginalis and Giardia duodenalis . Antimicrob Agents Chemother 50:344–347
von AllmenN.,
BienzM.,
HemphillA.,
MüllerN.2004; Experimental infections of neonatal mice with cysts of Giardia lamblia clone GS/M-83–H7 are associated with an antigenic reset of the parasite. Infect Immun 72:4763–4771